Portage Buys Tarus, Gaining Cancer Assets Targeting Immune Evasion

 
• By Jessica Merrill
  
magnet
Portage picked up Tarus in a stock-based acquisition. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business